Clinical Trial Update: PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Percutaneous Stem Cell Injection in dilated cardiomyopathy (POSEIDON-DCM) spanning Phase 1 and Phase 2, completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-ischemic Dilated Cardiomyopathy

Drugs mentioned

• Percutaneous stem cell injection

Snippet

Sponsor: Joshua M Hare | Conditions: Non-ischemic Dilated Cardiomyopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-15